Responses regarding reasons to use routinely collected data for health research
| Area; item | No. (%) of respondents n = 151 | |
|---|---|---|
| Most important* | Want additional information about† | |
| Benefits of using big data | ||
| Study long-term effects and rare events | 114 (75.5) | 96 (63.6) |
| Study large numbers | 110 (72.8) | 67 (44.4) |
| Study potentially harmful treatments | 76 (50.3) | 97 (64.2) |
| General population comparisons | 70 (46.4) | 63 (41.7) |
| More inclusive | 65 (43.0) | 53 (35.1) |
| Benefits of using big data from Canada | ||
| Reflective of Canadian health care system | 100 (66.2) | – |
| More inclusive | 96 (63.6) | – |
| Universal prescription medication data | 54 (35.8) | – |
| Reflective of Canadian population | 42 (27.8) | – |
| Issues to study using big data | ||
| Treatment benefits | 84 (55.6) | – |
| Treatment harms | 83 (55.0) | – |
| Disease complications | 79 (52.3) | – |
| Changes in policy or practice | 66 (43.7) | – |
| Quality of care | 46 (30.5) | – |
| Cost-effectiveness | 42 (27.8) | – |
| Risk factors for disease | 35 (23.2) | – |
| Disease incidence and prevalence | 15 (9.9) | – |